Healthcare Stocks for Every Stage of Life: LLY, UNH, and JNJ

When it comes to investing in healthcare stocks, age and risk tolerance play significant roles. Conventional wisdom suggests that younger investors focus on decades-long growth exposure, while middle-aged investors seek a balance between growth and yield. Older investors tend to prioritize income generation.

The healthcare sector has been on a tear since its unremarkable start to the year, with high-growth drugmakers like Eli Lilly & Co. (LLY) offering attractive opportunities for various investor age groups. LLY's dynamic portfolio of diabetes, cancer, Alzheimer's, and obesity drugs drives growth, with its lineup of obesity treatments being a particular driver.

For younger investors, LLY provides a modest dividend yield of 0.61% and has increased its payout for 11 consecutive years. The company's five-year annualized dividend growth rate is 15.18%. Analysts predict the global obesity treatment market will grow at a compound annual growth rate (CAGR) of 22.3% from 2025 to 2030, while the GLP-1 weight loss drug market will see an 18.5% CAGR during the same period.

For middle-aged investors, UnitedHealth Group (UNH) offers a combination of growth and yield. The company's Medicaid performance is improving, with management expecting margins closer to 1.1% loss rather than the previous 1.7% loss it projected. UNH has posted four consecutive earnings beats and raised its full-year 2026 outlook to adjusted earnings per share (EPS) of $19.50 to $20.

For older investors, Johnson & Johnson (JNJ) is a steady portfolio compounder with a history of dividend growth. The company yields 2.03% and has increased its payout for 14 years. JNJ's five-year annualized dividend growth rate is 5.25%, but the stock has posted a 28% year-to-date gain, making it an attractive option for those seeking both growth and income.